S|P|O
KDR|causes or contributes to condition|Lung adenocarcinoma
FGFR3|causes or contributes to condition|Lung adenocarcinoma
PRKCD|participates_in|PLC-gamma1 signalling
PRKCE|participates_in|PLC-gamma1 signalling
PRKCD|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
RAC1|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCD|participates_in|Signaling by ERBB2
RHOA|participates_in|Signaling by ERBB2
CDC42|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCB|participates_in|VEGFR2 mediated cell proliferation
PRKCZ|participates_in|VEGFR2 mediated cell proliferation
PRKCB|participates_in|G alpha (z) signalling events
PRKCQ|participates_in|G alpha (z) signalling events
PRKCB|participates_in|Signal Transduction
PRKCI|participates_in|Signal Transduction
PRKAB1|participates_in|Generic Transcription Pathway
YAP1 (human)|participates_in|Generic Transcription Pathway
WWTR1|participates_in|Generic Transcription Pathway
PRKCH|participates_in|Platelet activation, signaling and aggregation
CDC42|participates_in|Platelet activation, signaling and aggregation
RHOA|participates_in|Platelet activation, signaling and aggregation
PRKCH|participates_in|G alpha (z) signalling events
PRKCG|participates_in|PLC-gamma1 signalling
PRKCB|participates_in|VEGFA-VEGFR2 Pathway
CDC42|participates_in|VEGFA-VEGFR2 Pathway
PRKCD|participates_in|Effects of PIP2 hydrolysis
PRKCQ|participates_in|Effects of PIP2 hydrolysis
SMAD3|participates_in|SMAD4 MH2 Domain Mutants in Cancer
SMAD2 (human)|participates_in|SMAD4 MH2 Domain Mutants in Cancer
TCF7|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
CTNNB1 (human)|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
TCF7L2|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
TCF7L1|participates_in|Binding of TCF/LEF:CTNNB1 to target gene promoters
PRKCD|participates_in|G alpha (z) signalling events
PRKAG3|participates_in|Generic Transcription Pathway
PRKCB|participates_in|Disinhibition of SNARE formation
PRKCG|participates_in|Disinhibition of SNARE formation
PRKCB|participates_in|PCP/CE pathway
RHOA|participates_in|PCP/CE pathway
PRKCH|participates_in|Effects of PIP2 hydrolysis
RAC1|participates_in|PCP/CE pathway
PRKAG2|participates_in|Generic Transcription Pathway
PRKCQ|participates_in|Netrin-1 signaling
RAC1|participates_in|Netrin-1 signaling
CDC42|participates_in|Netrin-1 signaling
PRKCI|causes or contributes to condition|Bipolar affective disorder
PRKCZ|causes or contributes to condition|Bipolar affective disorder
PRKCQ|participates_in|Signal Transduction
PRKCI|participates_in|p75 NTR receptor-mediated signalling
RAC1|participates_in|p75 NTR receptor-mediated signalling
RHOA|participates_in|p75 NTR receptor-mediated signalling
CDC42|participates_in|Signal Transduction
LATS2|participates_in|Signaling by Hippo
YAP1 (human)|participates_in|Signaling by Hippo
GNAQ|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCH|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCZ|participates_in|Platelet activation, signaling and aggregation
PRKACA|participates_in|MAPK6/MAPK4 signaling
RAC1|participates_in|MAPK6/MAPK4 signaling
PRKAA2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKAG2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PRKCG|causes or contributes to condition|Allodynia
PRKCZ|causes or contributes to condition|Allodynia
PRKCG|participates_in|G alpha (z) signalling events
PRKCG|participates_in|Signaling by NTRKs
PRKCI|participates_in|Signaling by NTRKs
PRKCD|participates_in|Signaling by NTRKs
PRKCG|participates_in|PCP/CE pathway
PRKCG|participates_in|Signaling by EGFR
CDC42|participates_in|Signaling by EGFR
PRKCE|causes or contributes to condition|Allodynia
PRKCE|participates_in|Effects of PIP2 hydrolysis
PRKCE|participates_in|Signaling by NTRKs
PRKCE|participates_in|Fcgamma receptor (FCGR) dependent phagocytosis
PRKCE|participates_in|Signaling by ERBB2
PRKCD|participates_in|VEGFR2 mediated cell proliferation
PRKCQ|participates_in|Platelet activation, signaling and aggregation
PRKCQ|causes or contributes to condition|Cutaneous T-cell lymphoma
RHOA|causes or contributes to condition|Cutaneous T-cell lymphoma
PRKAG2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAG3|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PLCB2|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCE|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCZ|participates_in|GPVI-mediated activation cascade
CDC42|participates_in|GPVI-mediated activation cascade
F-actin|subClassOf|macromolecular complex
temozolomide|molecularly interacts with|macromolecular complex
temozolomide|is substance that treats|gemistocytic astrocytoma
LATS2|causes or contributes to condition|gemistocytic astrocytoma
PLCB2|participates_in|Beta-catenin independent WNT signaling
PRKCB|participates_in|Beta-catenin independent WNT signaling
PLCB1|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PLCB2|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PLCB1|causes or contributes to condition|Bipolar affective disorder
PLCB1|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCQ|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKAB2|participates_in|AMPK inhibits chREBP transcriptional activation activity
PLCB1|participates_in|PLC beta mediated events
PRKCG|participates_in|PLC beta mediated events
PRKCD|participates_in|PLC beta mediated events
CDH7|subClassOf|protein_coding_gene
NF2|subClassOf|protein_coding_gene
PLCB2|participates_in|PLC beta mediated events
GNA11|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
CDH9|subClassOf|protein_coding_gene
CDH8|participates_in|Adherens junctions interactions
CDH9|participates_in|Adherens junctions interactions
CDH8|subClassOf|protein_coding_gene
CDH7|participates_in|Adherens junctions interactions
CDH5|participates_in|Adherens junctions interactions
RAC1|participates_in|Platelet activation, signaling and aggregation
diethylstilbestrol|molecularly interacts with|macromolecular complex
diethylstilbestrol|is substance that treats|Epithelial neoplasm
LATS1|causes or contributes to condition|Epithelial neoplasm
CDH15|subClassOf|protein_coding_gene
CDH22|subClassOf|protein_coding_gene
CDH4|participates_in|Adherens junctions interactions
PLCB2|participates_in|Signal Transduction
PRKAB2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKAB2|participates_in|Generic Transcription Pathway
PRKAB1|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
PRKCE|participates_in|G alpha (z) signalling events
PRKAA2|participates_in|Activation of PPARGC1A (PGC-1alpha) by phosphorylation
GNA11|causes or contributes to condition|Iris melanoma
GNAQ|causes or contributes to condition|Iris melanoma
PRKCH|participates_in|Signal Transduction
PRKAA2|participates_in|Generic Transcription Pathway
WWTR1|causes or contributes to condition|epithelioid hemangioendothelioma
YAP1 (human)|causes or contributes to condition|epithelioid hemangioendothelioma
PRKAA1|participates_in|PKB-mediated events
PRKAG3|participates_in|PKB-mediated events
PRKAG2|participates_in|PKB-mediated events
PRKAB2|participates_in|PKB-mediated events
PRKAB1|participates_in|PKB-mediated events
PRKAA2|participates_in|PKB-mediated events
PRKAA1|participates_in|Generic Transcription Pathway
GNAQ|participates_in|Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
PRKCZ|participates_in|Signal Transduction
RAC1|participates_in|GPVI-mediated activation cascade
PRKACB|participates_in|PKA activation in glucagon signalling
PRKAR2A|participates_in|PKA activation in glucagon signalling
GNAL|participates_in|GPCR downstream signalling
RHOA|participates_in|GPCR downstream signalling
GNAL|causes or contributes to condition|Schizophrenia
CDC42|causes or contributes to condition|Schizophrenia
RAC1|participates_in|GPCR downstream signalling
GNAS|participates_in|Hemostasis
RHOA|participates_in|Hemostasis
GNAS|causes or contributes to condition|Neoplasm of the adrenal gland
CDC42|causes or contributes to condition|Neoplasm of the adrenal gland
RAC1|participates_in|Hemostasis
GNA11|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
PRKCD|participates_in|Gastrin-CREB signalling pathway via PKC and MAPK
GNAQ|participates_in|Signal Transduction
FGFR3|subClassOf|gene
NF2|subClassOf|gene
GNAQ|participates_in|Platelet activation, signaling and aggregation
PRKCB|participates_in|Platelet activation, signaling and aggregation
GNA11|participates_in|Signal Transduction
GNA11|participates_in|Platelet activation, signaling and aggregation
NTRK1|subClassOf|gene
PRKCZ|participates_in|TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
RHOA|participates_in|TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
KDR|subClassOf|gene
FLT4|causes or contributes to condition|Clear cell renal cell carcinoma
NF2|causes or contributes to condition|Clear cell renal cell carcinoma
CSF1R|subClassOf|gene
TEK|causes or contributes to condition|Clear cell renal cell carcinoma
MET|causes or contributes to condition|Malignant mesothelioma
NF2|causes or contributes to condition|Malignant mesothelioma
FLT1|causes or contributes to condition|Clear cell renal cell carcinoma
PRKCG|participates_in|Platelet activation, signaling and aggregation
KIT|causes or contributes to condition|Malignant mesothelioma
NGFR|participates_in|Signal Transduction
NF2|participates_in|Signal Transduction
PLCB2|participates_in|GPCR downstream signalling
CDC42|participates_in|GPCR downstream signalling
GNA11|causes or contributes to condition|cutaneous melanoma
RAC1|causes or contributes to condition|cutaneous melanoma
PLCB1|participates_in|G-protein beta:gamma signalling
RHOA|participates_in|G-protein beta:gamma signalling
PLCB1|causes or contributes to condition|Schizophrenia
PLCB1|participates_in|Beta-catenin independent WNT signaling
RAC1|participates_in|Beta-catenin independent WNT signaling
PLCB2|participates_in|G-protein beta:gamma signalling
TEAD1|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD4 (human)|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
TEAD2|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
STK4|participates_in|Signal Transduction
LATS1|participates_in|Signal Transduction
LATS2|participates_in|Signal Transduction
STK3|participates_in|Signal Transduction
CDH3|participates_in|Adherens junctions interactions
CDH3|subClassOf|gene
STK3|participates_in|Signaling by Hippo
LATS1|participates_in|Signaling by Hippo
LATS1|causes or contributes to condition|gemistocytic astrocytoma
TEAD3|participates_in|YAP1- and WWTR1 (TAZ)-stimulated gene expression
GNAS|participates_in|PKA activation in glucagon signalling
PRKAR1A|participates_in|PKA activation in glucagon signalling
PRKACA|causes or contributes to condition|Neoplasm of the adrenal gland
GNAS|causes or contributes to condition|Schizophrenia
GNAL|participates_in|G-protein mediated events
PRKAR2B|participates_in|G-protein mediated events
PRKAR2A|participates_in|G-protein mediated events
PRKAR1B|participates_in|G-protein mediated events
PRKAR1A|participates_in|G-protein mediated events
PRKACB|participates_in|G-protein mediated events
PRKACA|participates_in|G-protein mediated events
WWTR1|participates_in|Signaling by Hippo
PRKAR2B|participates_in|PKA activation in glucagon signalling
PRKAR1B|participates_in|PKA activation in glucagon signalling
CDH5|participates_in|Signal Transduction
PRKACB|participates_in|PKA activation
PRKAR2B|participates_in|PKA activation
PRKACB|participates_in|MAPK6/MAPK4 signaling
PRKACB|participates_in|VEGFA-VEGFR2 Pathway
RHOA|participates_in|VEGFA-VEGFR2 Pathway
CDC42|participates_in|MAPK6/MAPK4 signaling
PRKACA|participates_in|PKA activation
NGFR|participates_in|Signaling by NTRKs
PDGFRB|participates_in|Signaling by NTRKs
CDH1|participates_in|Adherens junctions interactions
CDH11|participates_in|Adherens junctions interactions
PRKAR2A|participates_in|PKA activation
PRKAR1B|participates_in|PKA activation
GNAI3|participates_in|Platelet activation, signaling and aggregation
PRKAR1A|participates_in|Factors involved in megakaryocyte development and platelet production
CDC42|participates_in|Factors involved in megakaryocyte development and platelet production
RAC1|causes or contributes to condition|dilated cardiomyopathy 1A
hydralazine|is substance that treats|dilated cardiomyopathy 1A
hydralazine|molecularly interacts with|macromolecular complex
RHOA|participates_in|Sema4D mediated inhibition of cell attachment and migration
RAC1|participates_in|Sema4D mediated inhibition of cell attachment and migration
valproic acid|interacts with|RHOA
valproic acid|molecularly interacts with|macromolecular complex
CDC42|participates_in|Inactivation of CDC42 and RAC1
RAC1|participates_in|Inactivation of CDC42 and RAC1
CDC42|participates_in|RHO GTPases activate KTN1
RHOA|participates_in|RHO GTPases activate KTN1
aflatoxin B1|interacts with|CDC42
aflatoxin B1|molecularly interacts with|macromolecular complex
GNAI2|participates_in|Adenylate cyclase inhibitory pathway
GNAI3|participates_in|Adenylate cyclase inhibitory pathway
PRKACA|participates_in|PKA-mediated phosphorylation of key metabolic factors
PRKACB|participates_in|PKA-mediated phosphorylation of key metabolic factors
GNAI2|participates_in|Platelet activation, signaling and aggregation
GNAI2|causes or contributes to condition|Carcinoma
CDC42|causes or contributes to condition|Carcinoma
TEK|participates_in|Signalling to p38 via RIT and RIN
NTRK1|participates_in|Signalling to p38 via RIT and RIN
PRKAR1A|participates_in|PKA activation
PDGFRB|participates_in|PI3K/AKT activation
NTRK1|participates_in|PI3K/AKT activation
PDGFRB|participates_in|SOS-mediated signalling
TEK|participates_in|SOS-mediated signalling
MET|participates_in|SOS-mediated signalling
PRKAR1A|causes or contributes to condition|Frontal balding
RHOA|causes or contributes to condition|Frontal balding
CDH24|participates_in|Adherens junctions interactions
CDH1|subClassOf|protein_coding_gene
CDH20|subClassOf|protein_coding_gene
CDH2|participates_in|Adherens junctions interactions
CDH17|participates_in|Adherens junctions interactions
CDH13|participates_in|Adherens junctions interactions
CDH10|participates_in|Adherens junctions interactions
RAC1|participates_in|Factors involved in megakaryocyte development and platelet production
CDH1|causes or contributes to condition|mesothelioma
NF2|causes or contributes to condition|mesothelioma
PRKAR2B|participates_in|Signaling by NTRK1 (TRKA)
RHOA|participates_in|Signaling by NTRK1 (TRKA)
PRKAR2A|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR2A|participates_in|Signaling by NTRK1 (TRKA)
PRKAR1B|participates_in|Factors involved in megakaryocyte development and platelet production
PRKAR1B|participates_in|Signaling by NTRK1 (TRKA)
PRKAR2B|participates_in|Factors involved in megakaryocyte development and platelet production
MET|causes or contributes to condition|Neuroblastoma
NTRK1|causes or contributes to condition|Neuroblastoma
MET|participates_in|PI3K/AKT activation
FLT1|causes or contributes to condition|sarcomatoid renal cell carcinoma
MET|causes or contributes to condition|sarcomatoid renal cell carcinoma
CDH12|participates_in|Adherens junctions interactions
FGFR3|causes or contributes to condition|gliosarcoma
EGFR|causes or contributes to condition|gliosarcoma
KIT|participates_in|Signaling by VEGF
FLT4|participates_in|Signaling by VEGF
KIT|causes or contributes to condition|Neoplasm of the skin
FLT1|causes or contributes to condition|Neoplasm of the skin
KIT|causes or contributes to condition|Breast carcinoma
CSF1R|causes or contributes to condition|Breast carcinoma
KIT|participates_in|TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
EGFR|participates_in|TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
FGFR3|participates_in|PI3K/AKT activation
FGFR3|participates_in|SOS-mediated signalling
FGFR3|participates_in|Signaling by NTRKs
EGFR|participates_in|Signaling by Interleukins
CSF1R|participates_in|Signaling by Interleukins
FGFR3|participates_in|Signaling by VEGF
FGFR3|participates_in|Signaling by Interleukins
FGFR3|causes or contributes to condition|testicular germ cell tumor
KIT|causes or contributes to condition|testicular germ cell tumor
KIT|participates_in|PI3K/AKT activation
KDR|causes or contributes to condition|Schizophrenia
NTRK1|causes or contributes to condition|Schizophrenia
KDR|causes or contributes to condition|temporal lobe epilepsy
TEK|causes or contributes to condition|temporal lobe epilepsy
KDR|participates_in|VEGFR2 mediated cell proliferation
PDGFRB|participates_in|VEGFR2 mediated cell proliferation
KDR|causes or contributes to condition|Esophageal neoplasm
MET|causes or contributes to condition|Esophageal neoplasm
NGFR|causes or contributes to condition|Schizophrenia
KDR|causes or contributes to condition|capillary infantile hemangioma
FLT4|causes or contributes to condition|capillary infantile hemangioma
KDR|participates_in|Neurophilin interactions with VEGF and VEGFR
FLT1|participates_in|Neurophilin interactions with VEGF and VEGFR
EGFR|causes or contributes to condition|Esophageal neoplasm
KIT|participates_in|VEGFR2 mediated cell proliferation
FLT1|causes or contributes to condition|Lung adenocarcinoma
EGFR|participates_in|Signaling by VEGF
FLT1|participates_in|Signaling by VEGF
NTRK1|participates_in|Signaling by NTRKs
TEK|participates_in|Signaling by NTRKs
RHOA|causes or contributes to condition|Carcinoma
MET|participates_in|Signaling by NTRKs
FLT4|subClassOf|gene
KIT|participates_in|SOS-mediated signalling
KIT|participates_in|Signaling by NTRKs
PDGFRB|participates_in|Signaling by VEGF
MET|participates_in|Signaling by VEGF
FLT4|participates_in|Signal Transduction
FLT1|participates_in|Signal Transduction
NTRK1|participates_in|Signal Transduction
pesticide|interacts with|EGFR
pesticide|interacts with|NGFR
FLT1|participates_in|VEGF binds to VEGFR leading to receptor dimerization
FLT4|participates_in|VEGF binds to VEGFR leading to receptor dimerization
TEK|participates_in|Signaling by Interleukins
PDGFRB|participates_in|Signaling by Interleukins
CSF1R|causes or contributes to condition|Acute megakaryocytic leukemia
MET|causes or contributes to condition|Acute megakaryocytic leukemia
CSF1R|subClassOf|protein_coding_gene
NGFR|subClassOf|protein_coding_gene
FLT1|causes or contributes to condition|Breast carcinoma
EGFR|participates_in|PI3K/AKT activation
EGFR|participates_in|SOS-mediated signalling
MTOR|causes or contributes to condition|mesothelioma
CDH2|participates_in|Myogenesis
CDH4|participates_in|Myogenesis
CDH2|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH20
aflatoxin B1|interacts with|CDH22
CDH24|subClassOf|protein_coding_gene
CDH17|subClassOf|protein_coding_gene
CDH15|participates_in|Adherens junctions interactions
CDH2|subClassOf|gene
CDH15|participates_in|Myogenesis
PDGFRB|subClassOf|gene
CDH4|subClassOf|protein_coding_gene
PRKACA|participates_in|VEGFA-VEGFR2 Pathway
CDH3|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH8
CDH22|causes or contributes to condition|Neoplasm of the large intestine
CDH7|causes or contributes to condition|Neoplasm of the large intestine
CDH5|causes or contributes to condition|Neoplasm of the large intestine
aflatoxin B1|interacts with|CDH7
aflatoxin B1|interacts with|CDH5
aflatoxin B1|interacts with|CDH11
aflatoxin B1|interacts with|CDH10
CDH10|subClassOf|protein_coding_gene
CDH11|subClassOf|protein_coding_gene
CDH12|subClassOf|protein_coding_gene
CDH15|subClassOf|gene
CDH13|subClassOf|protein_coding_gene
aflatoxin B1|interacts with|CDH12
EGFR|causes or contributes to condition|Malignant mesothelioma
